MHY5456, an FXR Agonist, Ameliorates Hepatic Steatosis and Fibrosis in a Mouse Model of MASLD

BIOMOLECULES & THERAPEUTICS · Published 2026-04-30 · DOI 10.4062/biomolther.2025.256

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.4062/biomolther.2025.256

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles